Fingerprint
Dive into the research topics of 'PRMT1 confers resistance to olaparib via modulating MYC signaling in triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PRMT1 confers resistance to olaparib via modulating MYC signaling in triple-negative breast cancer
Wen Jing Hsu, Cheng Hsun Chen, Yu Chu Chang, Chia Hsiung Cheng, Ying Huei Tsai, Cheng Wei Lin
- TMU Research Center of Urology and Kidney
- Taipei Municipal Wanfang Hospital
- Division of Nephrology
- Department of Biochemistry and Molecular Cell Biology
- International Ph.D. Program for Cell Therapy and Regeneration Medicine
- TMU Research Center of Cell Therapy and Regeneration Medicine
- Graduate Institute of Medical Sciences
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery
- Taipei Heart Institute (THI), Taipei Medical University
- TMU Research Center of Thoracic Medicine
- TMU Research Center of Cancer Translational Medicine
Research output: Contribution to journal › Article › peer-review
4
Citations
(Scopus)